Cellnovo and Home Diagnostics form alliance to advance diabetes
8 June 2010
London-based Cellnovo and US company Home Diagnostics, Inc.
have formed a strategic alliance to integrate technologies and develop
distribution opportunities for Cellnovo’s insulin patch pumps.
The partnership allows both companies to accelerate their growth
and has the potential to transform the pump industry.
The first phase of the agreement calls for the inclusion of Home
Diagnostics TRUE blood glucose technology in the Cellnovo wireless
mobile handset. The companies will also begin exploring ways to
leverage Home Diagnostics’ distribution network to expand Cellnovo’s
presence in the United States and other countries.
“We are extremely excited about our partnership with Home
Diagnostics,” said Bill McKeon, Chief Executive Officer of Cellnovo.
“On a technical level, it will provide our customers with the most
advanced blood glucose monitoring technology available today within
our mobile handset. From a business perspective, it provides an
extensive distribution network that includes 45,000 points of
distribution, leading insurance companies and major product order
The Home Diagnostics blood glucose unit will operate as a
built-in meter within the Cellnovo handset, enabling patients to
monitor their blood sugar using touchscreen controls and TRUEresult
and TRUEtest Test Strips. Like all information in the handset, the
glucose readings will be automatically stored and sent wirelessly to
physicians, clinicians and family members.
“Our agreement with Cellnovo allows us to leverage the emerging
opportunities in the insulin pump market through the most innovative
pump system in the industry,” said Joseph H. Capper, Home
Diagnostics’ President. “We look forward to helping Cellnovo bring
the convenience, ease-of-use and wireless capabilities of their
visionary product to diabetes patients throughout the U.S. and
The Cellnovo pump, which is available in three models, is the
industry’s smallest patch pump and the first to offer wireless,
touchscreen operation. With the integration of the Home Diagnostics
blood glucose meter, patients can monitor their glucose levels using
the same handset that records their insulin use, daily meals and
activity levels, making diabetes management easier and more
“The combination of Home Diagnostics’ leadership technology and
its significant distribution channels positions us to not only drive
new advancements in health care, but to also bring greater freedom
and convenience to diabetes patients worldwide”, said McKeon.